lobbying_activities: 1416952

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1416952	299bca32-25b2-4326-9f42-e9277ef126ed	Q2	AMERICAN ASSOCIATION OF NURSE PRACTITIONERS	401040928	AMERICAN ASSOCIATION OF NURSE PRACTITIONERS	2013	second_quarter	PHA	Legislation and policies relating to: FDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substance H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drugS. 621 Safe Prescribing Act H.R. 1919 - Safeguarding America's Pharmaceuticals Act H.R. 2186 VALID Compounding Act S. 959 Pharmaceutical Compounding Quality and Accountability Act	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office		84089	0	0	2013-07-19T11:44:20.793000-04:00